Neurology and Neurosurgery

Episodes 129-144 of 413

Advances in MS Management: Current and Future Directions
Advances in MS Management: Current and Future Directions
NeuroFrontiers
Advances in MS Management: Current and Future Directions
Diagnosing Duchenne Muscular Dystrophy: Recognizing Signs and Reducing Delays
Diagnosing Duchenne Muscular Dystrophy: Recognizing Signs and Reducing Delays
NeuroFrontiers
Diagnosing Duchenne Muscular Dystrophy: Recognizing Signs and Reducing Delays
- Nancy Kuntz, MD
Duchenne Muscular Dystrophy Management: Analyzing Current Approaches
Duchenne Muscular Dystrophy Management: Analyzing Current Approaches
NeuroFrontiers
Duchenne Muscular Dystrophy Management: Analyzing Current Approaches
- Nancy Kuntz, MD
From Trials to Practice: Evaluating Xanomeline-Trospium Chloride for Schizophrenia
From Trials to Practice: Evaluating Xanomeline-Trospium Chloride for Schizophrenia
NeuroFrontiers
From Trials to Practice: Evaluating Xanomeline-Trospium Chloride for Schizophrenia
- Ashley Baker, MSN, PMHNP
- Steven Paul, MD
Exploring Metabolomics in Multiple Sclerosis
Exploring Metabolomics in Multiple Sclerosis
NeuroFrontiers
Exploring Metabolomics in Multiple Sclerosis
- Pavan Barghava, MD
Metabolomics in Multiple Sclerosis: Advancing Diagnosis, Prognosis, and Treatment Response
Metabolomics in Multiple Sclerosis: Advancing Diagnosis, Prognosis, and Treatment Response
NeuroFrontiers
Metabolomics in Multiple Sclerosis: Advancing Diagnosis, Prognosis, and Treatment Response
- Pavan Barghava, MD
Safety Outcomes in MS Clinical Trials: Examining Comorbidities and Adverse Events
Safety Outcomes in MS Clinical Trials: Examining Comorbidities and Adverse Events
NeuroFrontiers
Safety Outcomes in MS Clinical Trials: Examining Comorbidities and Adverse Events
- Amber Salter, PhD
MS and the Ketogenic Diet: Potential Impacts on Inflammation and Relapse
MS and the Ketogenic Diet: Potential Impacts on Inflammation and Relapse
NeuroFrontiers
MS and the Ketogenic Diet: Potential Impacts on Inflammation and Relapse
- Michael Kornberg, MD, PhD
Managing Multiple Sclerosis: The Impact of Dietary Modifications
Managing Multiple Sclerosis: The Impact of Dietary Modifications
On the Frontlines of Multiple Sclerosis
Managing Multiple Sclerosis: The Impact of Dietary Modifications
- Charles Turck, PharmD, BCPS, BCCCP
- Anna A. Shah, MD
Strategies and Considerations for Managing MS in Pregnant Women
Strategies and Considerations for Managing MS in Pregnant Women
On the Frontlines of Multiple Sclerosis
Strategies and Considerations for Managing MS in Pregnant Women
- Charles Turck, PharmD, BCPS, BCCCP
- Anna A. Shah, MD
Cognitive Impairment in MS: Mitigating Impacts to Optimize Brain Health
Cognitive Impairment in MS: Mitigating Impacts to Optimize Brain Health
NeuroFrontiers
Cognitive Impairment in MS: Mitigating Impacts to Optimize Brain Health
- Christopher Lock, MD
Understanding Prodromal Phases in Demyelinating Diseases: Insights on MS, NMOSD, and MOGAD
Understanding Prodromal Phases in Demyelinating Diseases: Insights on MS, NMOSD, and MOGAD
NeuroFrontiers
Understanding Prodromal Phases in Demyelinating Diseases: Insights on MS, NMOSD, and MOGAD
- Dalia Rotstein, MD, MPH
Emerging Technologies in MS: Neuromodulation and Myelin Regeneration
Emerging Technologies in MS: Neuromodulation and Myelin Regeneration
NeuroFrontiers
Emerging Technologies in MS: Neuromodulation and Myelin Regeneration
- Cristin Welle, PhD
MS and Structural Disconnectivity: Pathophysiology and Emerging Technologies
MS and Structural Disconnectivity: Pathophysiology and Emerging Technologies
NeuroFrontiers
MS and Structural Disconnectivity: Pathophysiology and Emerging Technologies
- Amy Kuceyeski, PhD
Multiple Sclerosis Explained: Understanding Its Epidemiology
Multiple Sclerosis Explained: Understanding Its Epidemiology
NeuroFrontiers
Multiple Sclerosis Explained: Understanding Its Epidemiology
- Jonathan E. Howard, MD
Generalized Myasthenia Gravis Management: Evaluating Long-Term Effects
Generalized Myasthenia Gravis Management: Evaluating Long-Term Effects
NeuroFrontiers
Generalized Myasthenia Gravis Management: Evaluating Long-Term Effects
- Maxwell H. Levy, MD

9/11

Neurology and Neurosurgery

Episodes 129-144 of 413

NEED HELP?

Contact us

NEED HELP?

Contact us

Episodes 129-144 of 413

Title

Share on ReachMD